Supplemental Figures
Figure 1 (A, D-G) Quantitative analysis of the Western blot results. The data are shown as the means ± SDs from 3 experiments. (B) Immunofluorescence staining of iNOS (Alexa Fluor 594, red) and DAPI nuclear staining in the kidney (200× magnification; scale bar 100 μm). (C) IHC analysis of CD86 expression. (200× magnification; scale bar 100 μm).
Figure 2 (A-D) IHC analysis of CD86 expression. (200× magnification; scale bar 100 μm). (E-F) Quantitative analysis of the Western blot results. The data are shown as the means ± SDs from 3 experiments.
Figure 3 (A, B) Quantitative analysis of the Western blot results. The data are shown as the means ± SDs from 3 experiments.
Figure 4 (A-C) Quantitative analysis of the Western blot results. The data are shown as the means ± SDs from 3 experiments.
Figure 5 (A-C) Quantitative analysis of the Western blot results. The data are shown as the means ± SDs from 3 experiments.
References:
Agostini, L., F. Martinon, K. Burns, M. F. McDermott, P. N. Hawkins and J. Tschopp (2004). ”NALP3 forms an IL-1beta-processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder.”Immunity 20 (3): 319-325https://doi.org/10.1016/s1074-7613(04)00046-9 .
Anders, H. J. and M. Ryu (2011). ”Renal microenvironments and macrophage phenotypes determine progression or resolution of renal inflammation and fibrosis.” Kidney Int 80 (9): 915-925https://doi.org/10.1038/ki.2011.217 .
Baek, K. J., S. Ji, Y. C. Kim and Y. Choi (2015). ”Association of the invasion ability of Porphyromonas gingivalis with the severity of periodontitis.” Virulence 6 (3): 274-281https://doi.org/10.1080/21505594.2014.1000764 .
Bao, H. and A. Peng (2016). ”The Green Tea Polyphenol(-)-epigallocatechin-3-gallate and its beneficial roles in chronic kidney disease.” J Transl Int Med 4 (3): 99-103https://doi.org/10.1515/jtim-2016-0031 .
Bhargava, S., E. Merckelbach, H. Noels, A. Vohra and J. Jankowski (2022). ”Homeostasis in the Gut Microbiota in Chronic Kidney Disease.”Toxins (Basel)14 (10)https://doi.org/10.3390/toxins14100648 .
Bui, F. Q., C. L. C. Almeida-da-Silva, B. Huynh, A. Trinh, J. Liu, J. Woodward, H. Asadi, . . . D. M. Ojcius (2019). ”Association between periodontal pathogens and systemic disease.” Biomed J42 (1): 27-35https://doi.org/10.1016/j.bj.2018.12.001 .
Coresh, J., E. Selvin, L. A. Stevens, J. Manzi, J. W. Kusek, P. Eggers, F. Van Lente, . . . A. S. Levey (2007). ”Prevalence of chronic kidney disease in the United States.” JAMA 298 (17): 2038-2047https://doi.org/10.1001/jama.298.17.2038 .
D’Aiuto, F., M. Parkar, G. Andreou, J. Suvan, P. M. Brett, D. Ready and M. S. Tonetti (2004). ”Periodontitis and systemic inflammation: control of the local infection is associated with a reduction in serum inflammatory markers.” J Dent Res 83 (2): 156-160https://doi.org/10.1177/154405910408300214 .
Deschamps-Lenhardt, S., R. Martin-Cabezas, T. Hannedouche and O. Huck (2019). ”Association between periodontitis and chronic kidney disease: Systematic review and meta-analysis.” Oral Dis 25 (2): 385-402https://doi.org/10.1111/odi.12834 .
Dixon, S. J., K. M. Lemberg, M. R. Lamprecht, R. Skouta, E. M. Zaitsev, C. E. Gleason, D. N. Patel, . . . B. R. Stockwell (2012). ”Ferroptosis: an iron-dependent form of nonapoptotic cell death.” Cell149 (5): 1060-1072https://doi.org/10.1016/j.cell.2012.03.042 .
Fang, F., B. Wu, Q. Qu, J. Gao, W. Yan, X. Huang, D. Ma, . . . Y. Liu (2015). ”The clinical response and systemic effects of non-surgical periodontal therapy in end-stage renal disease patients: a 6-month randomized controlled clinical trial.” J Clin Periodontol42 (6): 537-546https://doi.org/10.1111/jcpe.12411 .
Fisher, M. A., G. W. Taylor, P. N. Papapanou, M. Rahman and S. M. Debanne (2008). ”Clinical and serologic markers of periodontal infection and chronic kidney disease.” J Periodontol 79 (9): 1670-1678https://doi.org/10.1902/jop.2008.070569 .
Genco, R. J. and W. S. Borgnakke (2013). ”Risk factors for periodontal disease.” Periodontol 2000 62 (1): 59-94https://doi.org/10.1111/j.1600-0757.2012.00457.x .
Giuliani, K. T. K., A. Grivei, P. Nag, X. Wang, M. Rist, K. Kildey, B. Law, . . . A. J. Kassianos (2022). ”Hypoxic human proximal tubular epithelial cells undergo ferroptosis and elicit an NLRP3 inflammasome response in CD1c(+) dendritic cells.” Cell Death Dis13 (8): 739https://doi.org/10.1038/s41419-022-05191-z .
Goncalves, A. C., L. S. Ferreira, F. A. Manente, C. de Faria, M. C. Polesi, C. R. de Andrade, D. S. Zamboni, . . . I. Z. Carlos (2017). ”The NLRP3 inflammasome contributes to host protection during Sporothrix schenckii infection.” Immunology 151 (2): 154-166https://doi.org/10.1111/imm.12719 .
Holden, J. A., T. J. Attard, K. M. Laughton, A. Mansell, N. M. O’Brien-Simpson and E. C. Reynolds (2014). ”Porphyromonas gingivalis lipopolysaccharide weakly activates M1 and M2 polarized mouse macrophages but induces inflammatory cytokines.” Infect Immun82 (10): 4190-4203https://doi.org/10.1128/IAI.02325-14 .
Huang, Y., C. Tian, Q. Li and Q. Xu (2019). ”TET1 Knockdown Inhibits Porphyromonas gingivalis LPS/IFN-gamma-Induced M1 Macrophage Polarization through the NF-kappaB Pathway in THP-1 Cells.” Int J Mol Sci 20 (8)https://doi.org/10.3390/ijms20082023 .
Iwasaki, M., G. W. Taylor, M. C. Manz, N. Kaneko, S. Imai, A. Yoshihara and H. Miyazaki (2012). ”Serum antibody to Porphyromonas gingivalis in chronic kidney disease.” J Dent Res 91 (9): 828-833https://doi.org/10.1177/0022034512455063 .
Jha, V., G. Garcia-Garcia, K. Iseki, Z. Li, S. Naicker, B. Plattner, R. Saran, . . . C. W. Yang (2013). ”Chronic kidney disease: global dimension and perspectives.” Lancet 382 (9888): 260-272https://doi.org/10.1016/S0140-6736(13)60687-X .
Jiao, J., W. Jing, Y. Si, X. Feng, B. Tai, D. Hu, H. Lin, . . . X. Wang (2021). ”The prevalence and severity of periodontal disease in Mainland China: Data from the Fourth National Oral Health Survey (2015-2016).”J Clin Periodontol 48 (2): 168-179https://doi.org/10.1111/jcpe.13396 .
Jomen, W., T. Ohtake, T. Akita, D. Suto, H. Yagi, Y. Osawa and Y. Kohgo (2022). ”Iron chelator deferasirox inhibits NF-kappaB activity in hepatoma cells and changes sorafenib-induced programmed cell deaths.”Biomed Pharmacother 153 : 113363https://doi.org/10.1016/j.biopha.2022.113363 .
Kapellas, K., A. Singh, M. Bertotti, G. G. Nascimento, L. M. Jamieson and C. K. D. c. Perio (2019). ”Periodontal and chronic kidney disease association: A systematic review and meta-analysis.” Nephrology (Carlton) 24 (2): 202-212https://doi.org/10.1111/nep.13225 .
Kassebaum, N. J., E. Bernabe, M. Dahiya, B. Bhandari, C. J. Murray and W. Marcenes (2014). ”Global burden of severe periodontitis in 1990-2010: a systematic review and meta-regression.” J Dent Res93 (11): 1045-1053https://doi.org/10.1177/0022034514552491 .
Kon, V., M. F. Linton and S. Fazio (2011). ”Atherosclerosis in chronic kidney disease: the role of macrophages.” Nat Rev Nephrol7 (1): 45-54https://doi.org/10.1038/nrneph.2010.157 .
Kretz-Remy, C., P. Mehlen, M. E. Mirault and A. P. Arrigo (1996). ”Inhibition of I kappa B-alpha phosphorylation and degradation and subsequent NF-kappa B activation by glutathione peroxidase overexpression.” J Cell Biol 133 (5): 1083-1093https://doi.org/10.1083/jcb.133.5.1083 .
Lam, R. S., N. M. O’Brien-Simpson, J. A. Holden, J. C. Lenzo, S. B. Fong and E. C. Reynolds (2016). ”Unprimed, M1 and M2 Macrophages Differentially Interact with Porphyromonas gingivalis.” PLoS One11 (7): e0158629https://doi.org/10.1371/journal.pone.0158629 .
Lech, M., R. Grobmayr, M. Ryu, G. Lorenz, I. Hartter, S. R. Mulay, H. E. Susanti, . . . H. J. Anders (2014). ”Macrophage phenotype controls long-term AKI outcomes–kidney regeneration versus atrophy.” J Am Soc Nephrol 25 (2): 292-304https://doi.org/10.1681/ASN.2013020152 .
Lew, J. H., K. Naruishi, Y. Kajiura, Y. Nishikawa, T. Ikuta, J. I. Kido and T. Nagata (2018). ”High Glucose-Mediated Cytokine Regulation in Gingival Fibroblasts and THP-1 Macrophage: a Possible Mechanism of Severe Periodontitis with Diabetes.” Cell Physiol Biochem50 (3): 973-986https://doi.org/10.1159/000494481 .
Li, C., X. Y. Ding, D. M. Xiang, J. Xu, X. L. Huang, F. F. Hou and Q. G. Zhou (2015). ”Enhanced M1 and Impaired M2 Macrophage Polarization and Reduced Mitochondrial Biogenesis via Inhibition of AMP Kinase in Chronic Kidney Disease.” Cell Physiol Biochem 36 (1): 358-372https://doi.org/10.1159/000430106 .
Liu, L., H. Guo, A. Song, J. Huang, Y. Zhang, S. Jin, S. Li, . . . P. Yang (2020). ”Progranulin inhibits LPS-induced macrophage M1 polarization via NF-small ka, CyrillicB and MAPK pathways.” BMC Immunol 21 (1): 32https://doi.org/10.1186/s12865-020-00355-y .
Lv, J. C. and L. X. Zhang (2019). ”Prevalence and Disease Burden of Chronic Kidney Disease.” Adv Exp Med Biol 1165 : 3-15https://doi.org/10.1007/978-981-13-8871-2_1 .
Lv, X., C. Fan, Z. Jiang, W. Wang, X. Qiu and Q. Ji (2021). ”Isoliquiritigenin alleviates P. gingivalis-LPS/ATP-induced pyroptosis by inhibiting NF-kappaB/ NLRP3/GSDMD signals in human gingival fibroblasts.” Int Immunopharmacol 101 (Pt B): 108338https://doi.org/10.1016/j.intimp.2021.108338 .
Mahendra, J., P. Palathingal, L. Mahendra, K. J. Alzahrani, H. J. Banjer, K. F. Alsharif, I. F. Halawani, . . . S. Patil (2022). ”Impact of Red Complex Bacteria and TNF-alpha Levels on the Diabetic and Renal Status of Chronic Kidney Disease Patients in the Presence and Absence of Periodontitis.” Biology (Basel)11 (3)https://doi.org/10.3390/biology11030451 .
Mussbacher, M., M. Salzmann, C. Brostjan, B. Hoesel, C. Schoergenhofer, H. Datler, P. Hohensinner, . . . J. A. Schmid (2019). ”Cell Type-Specific Roles of NF-kappaB Linking Inflammation and Thrombosis.”Front Immunol 10 : 85https://doi.org/10.3389/fimmu.2019.00085 .
Navarrete, M., J. Garcia, N. Dutzan, L. Henriquez, J. Puente, P. Carvajal, M. Hernandez, . . . J. Gamonal (2014). ”Interferon-gamma, interleukins-6 and -4, and factor XIII-A as indirect markers of the classical and alternative macrophage activation pathways in chronic periodontitis.” J Periodontol 85 (5): 751-760https://doi.org/10.1902/jop.2013.130078 .
Palm, E., I. Demirel, T. Bengtsson and H. Khalaf (2015). ”The role of toll-like and protease-activated receptors in the expression of cytokines by gingival fibroblasts stimulated with the periodontal pathogen Porphyromonas gingivalis.” Cytokine 76 (2): 424-432https://doi.org/10.1016/j.cyto.2015.08.263 .
Pang, Q., P. Wang, Y. Pan, X. Dong, T. Zhou, X. Song and A. Zhang (2022). ”Irisin protects against vascular calcification by activating autophagy and inhibiting NLRP3-mediated vascular smooth muscle cell pyroptosis in chronic kidney disease.” Cell Death Dis13 (3): 283https://doi.org/10.1038/s41419-022-04735-7 .
Parsegian, K., D. Randall, M. Curtis and E. Ioannidou (2022). ”Association between periodontitis and chronic kidney disease.”Periodontol 2000 89 (1): 114-124https://doi.org/10.1111/prd.12431 .
Qiao, S., B. Li, Q. Cai, Z. Li, Z. Yin, J. He, Y. Li, . . . W. Meng (2022). ”Involvement of ferroptosis in Porphyromonas gingivalis lipopolysaccharide-stimulated periodontitis in vitro and in vivo.”Oral Dishttps://doi.org/10.1111/odi.14292 .
Rehnqvist, N. (1981). ”Clinical experience with intravenous metoprolol in supraventricular tachyarrhythmias. A multicentre study.” Ann Clin Res 13 Suppl 30 : 68-72
Ricardo, S. D., H. van Goor and A. A. Eddy (2008). ”Macrophage diversity in renal injury and repair.” J Clin Invest 118 (11): 3522-3530https://doi.org/10.1172/JCI36150 .
Sharma, P., T. Dietrich, A. Sidhu, V. Vithlani, M. Rahman, S. Stringer, M. Jesky, . . . I. L. Chapple (2014). ”The periodontal health component of the Renal Impairment In Secondary Care (RIISC) cohort study: a description of the rationale, methodology and initial baseline results.”J Clin Periodontol 41 (7): 653-661https://doi.org/10.1111/jcpe.12263 .
Siribamrungwong, M., K. Yothasamutr and K. Puangpanngam (2014). ”Periodontal treatment reduces chronic systemic inflammation in peritoneal dialysis patients.” Ther Apher Dial 18 (3): 305-308https://doi.org/10.1111/1744-9987.12105 .
Sucajtys-Szulc, E., A. Debska-Slizien, B. Rutkowski, M. Szolkiewicz, J. Swierczynski and R. T. Smolenski (2022). ”Hepatocyte Nuclear Factor 1alpha Proinflammatory Effect Linked to the Overexpression of Liver Nuclear Factor-kappaB in Experimental Model of Chronic Kidney Disease.”Int J Mol Sci23 (16)https://doi.org/10.3390/ijms23168883 .
Sun, X., J. Gao, X. Meng, X. Lu, L. Zhang and R. Chen (2021). ”Polarized Macrophages in Periodontitis: Characteristics, Function, and Molecular Signaling.” Front Immunol 12 : 763334https://doi.org/10.3389/fimmu.2021.763334 .
Tonetti, M. S., T. E. Van Dyke and E. F. P. A. A. P. w. Working group 1 of the joint (2013). ”Periodontitis and atherosclerotic cardiovascular disease: consensus report of the Joint EFP/AAP Workshop on Periodontitis and Systemic Diseases.” J Clin Periodontol 40 Suppl 14 : S24-29https://doi.org/10.1111/jcpe.12089 .
Vilela, E. M., J. A. Bastos, N. Fernandes, A. P. Ferreira, A. Chaoubah and M. G. Bastos (2011). ”Treatment of chronic periodontitis decreases serum prohepcidin levels in patients with chronic kidney disease.”Clinics (Sao Paulo) 66 (4): 657-662https://doi.org/10.1590/s1807-59322011000400022 .
Wang, J., Y. Liu, Y. Wang and L. Sun (2021). ”The Cross-Link between Ferroptosis and Kidney Diseases.” Oxid Med Cell Longev2021 : 6654887https://doi.org/10.1155/2021/6654887 .
Wang, L., X. Xu, M. Zhang, C. Hu, X. Zhang, C. Li, S. Nie, . . . M. Zhou (2023). ”Prevalence of Chronic Kidney Disease in China: Results From the Sixth China Chronic Disease and Risk Factor Surveillance.” JAMA Intern Med 183 (4): 298-310https://doi.org/10.1001/jamainternmed.2022.6817 .
Wang, Y., C. Li, Y. Wan, M. Qi, Q. Chen, Y. Sun, X. Sun, . . . L. Wang (2021). ”Quercetin-Loaded Ceria Nanocomposite Potentiate Dual-Directional Immunoregulation via Macrophage Polarization against Periodontal Inflammation.” Small 17 (41): e2101505https://doi.org/10.1002/smll.202101505 .
Wang, Y. J., Y. Y. Chen, C. M. Hsiao, M. H. Pan, B. J. Wang, Y. C. Chen, C. T. Ho, . . . R. J. Chen (2020). ”Induction of Autophagy by Pterostilbene Contributes to the Prevention of Renal Fibrosis via Attenuating NLRP3 Inflammasome Activation and Epithelial-Mesenchymal Transition.” Front Cell Dev Biol 8 : 436https://doi.org/10.3389/fcell.2020.00436 .
Wen, Y., X. Lu, J. Ren, J. R. Privratsky, B. Yang, N. P. Rudemiller, J. Zhang, . . . S. D. Crowley (2019). ”KLF4 in Macrophages Attenuates TNFalpha-Mediated Kidney Injury and Fibrosis.” J Am Soc Nephrol30 (10): 1925-1938https://doi.org/10.1681/ASN.2019020111 .
Xiao, Z., B. Kong, J. Fang, T. Qin, C. Dai, W. Shuai and H. Huang (2021). ”Ferrostatin-1 alleviates lipopolysaccharide-induced cardiac dysfunction.” Bioengineered 12 (2): 9367-9376https://doi.org/10.1080/21655979.2021.2001913 .
Xu, M., J. Tao, Y. Yang, S. Tan, H. Liu, J. Jiang, F. Zheng, . . . B. Wu (2020). ”Ferroptosis involves in intestinal epithelial cell death in ulcerative colitis.” Cell Death Dis 11 (2): 86https://doi.org/10.1038/s41419-020-2299-1 .
Yang, J., Y. Zhu, D. Duan, P. Wang, Y. Xin, L. Bai, Y. Liu, . . . Y. Xu (2018). ”Enhanced activity of macrophage M1/M2 phenotypes in periodontitis.” Arch Oral Biol 96 : 234-242https://doi.org/10.1016/j.archoralbio.2017.03.006 .
Yao, C., D. Lan, X. Li, Y. Wang and S. Qi (2023). ”Porphyromonas gingivalis triggers inflammation in hepatocyte depend on ferroptosis via activating the NF-kappaB signaling pathway.” Oral Dishttps://doi.org/10.1111/odi.14537 .
Yao, C., D. Lan, X. Li, Y. Wang, S. Qi and Y. Liu (2023). ”Porphyromonas gingivalis is a risk factor for the development of nonalcoholic fatty liver disease via ferroptosis.” Microbes Infect 25 (1-2): 105040https://doi.org/10.1016/j.micinf.2022.105040 .
Ye, Y., A. Chen, L. Li, Q. Liang, S. Wang, Q. Dong, M. Fu, . . . J. Yan (2022). ”Repression of the antiporter SLC7A11/glutathione/glutathione peroxidase 4 axis drives ferroptosis of vascular smooth muscle cells to facilitate vascular calcification.” Kidney Int 102 (6): 1259-1275https://doi.org/10.1016/j.kint.2022.07.034 .
Zhou, L., X. Xue, Q. Hou and C. Dai (2022). ”Targeting Ferroptosis Attenuates Interstitial Inflammation and Kidney Fibrosis.” Kidney Dis (Basel) 8 (1): 57-71https://doi.org/10.1159/000517723 .